Where should transcatheter aortic valve implantation go beyond 2012?

Journal of Cardiovascular Medicine

Volumn 13, Issue 8, 2012, Pages 516-523

  Dworakowski, Rafal ^a   MacCarthy, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

severe aortic stenosis; transcatheter aortic valve implantation; transcatheter valve in valve implantation

Indexed keywords

AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BRAIN EMBOLISM; COST EFFECTIVENESS ANALYSIS; HEART VALVE BIOPROSTHESIS; HEART VALVE SURGERY; MORTALITY; RISK BENEFIT ANALYSIS; STROKE; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR DISEASE;

AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRACRANIAL EMBOLISM; PROSTHESIS DESIGN; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 84864285663     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328354cdac     Document Type: Article

References (39)

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-3008. (Pubitemid 35440280)
2. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29:1463-1470. (Pubitemid 351806497)
3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231-1243. (Pubitemid 36834640)
4. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006; 47:1214-1223.
5. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116:755-763. (Pubitemid 47255993)
6. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50:69-76. (Pubitemid 46970878)
7. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Eurointervention 2008; 4:242-249.
8. Walther T, Kempfert J, Rastan A, et al. Transapical aortic valve implantation at 3 years. J Thorac Cardiovasc Surg 2011.
9. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116:I240-I245. (Pubitemid 47480797)
10. SmithCR, LeonMB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-2198.
11. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597-1607.
12. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122:62-69.
13. Thomas M, Schymik G, Walther T, et al.One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation 2011; 124:425-433.
14. Dworakowski R, MacCarthy PA, Monaghan M, et al. Transcatheter aortic valve implantation for severe aortic stenosis: a new paradigm for multidisciplinary intervention: a prospective cohort study. Am Heart J 2010; 160:237-243.
15. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57:253-269.
16. Sinning J-M, Ghanem A, Steinhäuser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3:1141-1149.
17. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010; 31:865-874.
18. Masson J-B, Lee M, Boone RH, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76:165-173.
19. Dewey TM, Brown DL, Herbert MA, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010; 89:758-767; discussion 767.
20. Schofer J, Schlüter M, Treede H, et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ Cardiovasc Interv 2008; 1:126-133.
21. Treede H, Tübler T, Reichenspurner H, et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg 2010; 140:897-903.
22. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheteraortic valve for transapical implantation: first inman implantation of the JenaValveTM. Eur J Cardiothorac Surg 2011; 40:761-763.
23. Webb JG, Altwegg L, Masson J-B, et al. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009; 53:1855-1858.
24. Etienne P-Y, Papadatos S, Khoury El E, et al. Transaortic transcatheter aortic valve implantation with the Edwards Sapien valve: feasibility, technical considerations, and clinical advantages. Ann Thorac Surg 2011; 92:746-748.
25. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg 2009; 87:276-283.
26. Bapat VV, Khawaja MZ, Attia R, et al. Transaortic transcatheter aortic valve implantation using Edwards SAPIEN valve: a novel approach. Catheter Cardiovasc Interv 2012; 79:733-740.
27. Fraccaro C, Napodano M, Tarantini G, et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv 2009; 2:828-833.
28. Schultz C, Moelker A, Tzikas A, et al. The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach. Eurointervention 2010; 6:505-511.
29. Altiok E, Koos R, Schröder J, et al. Comparison of two-dimensional and three-dimensional imaging techniques for measurement of aortic annulus diameters before transcatheter aortic valve implantation. Heart 2011; 97:1578-1584.
30. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J 2011; 32:140-147.
31. Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the prostar system in 118 cases. Catheter Cardiovasc Interv 2011.
32. Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg 2011; 40:475-479.
33. Drews T, Pasic M, Buz S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg 2011; 59:237-242.
34. Grube E, Naber C, Abizaid A, et al. Feasibility of transcatheter aortic valve implantation without balloon predilation: a pilot study. JACC Cardiovasc Interv 2011; 4:751-757.
35. Coeytaux RR, Williams JW, Gray RN, et al. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann Intern Med 2010; 153:314-324.
36. Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol 2010; 55:97-101.
37. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 2010; 121:1848-1857.
38. Kapetanakis EI, MacCarthy P, Monaghan M, et al. Trans-apical aortic valve implantation in a patient with stentless valve degeneration. Eur J Cardiothorac Surg 2011; 39:1051-1053.
39. Cheung AW, Gurvitch R, Ye J, et al. Transcatheter transapical mitral valvein- valve implantations for a failed bioprosthesis: a case series. J Thorac Cardiovasc Surg 2011; 141:711-715.